Application of triacontanol in preparing anti-cancer medicine
A technology for triacontanol and a drug is applied in the application field of triacontanol in the preparation of anticancer drugs, and achieves the effects of good medicinal prospects and strong pharmacological effects
Active Publication Date: 2008-06-04
KUNMING LONGJIN PHARMA
View PDF1 Cites 13 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Triacontanol used in human medicine has not been reported
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0033] The preparation of capsules: first take 100 grams of triacontanol and dissolve it in an appropriate amount of peanut oil; at the same time add starch and a small amount of cyclodextrin to granulate, put into the mixer and mix uniformly, dry at 60°C, take it out and pass through an 80 mesh screen. The hard capsules of No. 2 or No. 3 specifications can be made by filling the granules made of the above-mentioned triacontanol and auxiliary materials into hollow capsules using an automatic capsule filling machine.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more Abstract
The invention relates to the application of the existing chemical substance in the preparation of human medicine. The invention relates to the application of triacontanol in the preparation of the medicine for treating liver cancer. The invention relates to the application of triacontanol in the preparation of the medicine for treating lung cancer. The invention develops a new medical application of the existing compound of triacontanol and exploits a new application field. The triacontanol of the invention is safe and nontoxic, strong in pharmacological action, which promises bright medical prospect. The medicine prepared by the triacontanol of the invention can be a plurality of dosage forms such as tablets, capsules, dropping pills, sustained release preparation, as well as injection, freeze-drying, suspensions, and emulsion used for injection.
Description
Technical field [0001] The invention relates to the application of an existing chemical substance in the preparation of human medicine. Background technique [0002] Triacontanol, the molecular formula is C 30 H 62 O, the structural formula is CH 3 -(CH 2 ) 28 -CH 2 -OH, there have been a large number of reports in the prior art, all of which focus on the use of triacontanol as a growth regulator and nutrient for vegetables, fruits, plants and food crops, and it is also reported as a pesticide. Triacontanol has not been reported for use in human medicine. Summary of the invention [0003] The purpose of the present invention is to overcome the shortcomings of the prior art and provide a new application of triacontanol in the preparation of anticancer drugs for humans. [0004] The invention relates to the application of triacontanol as a medicine for treating liver cancer. [0005] The invention relates to the application of triacontanol as a medicine for treating colon cancer. ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/045A61P35/00A61P1/16A61P1/00A61P11/00
CPCA61K31/04A61P1/00A61P1/16A61P11/00A61P35/00
Inventor 张人伟程惠佳樊献俄
Owner KUNMING LONGJIN PHARMA
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap